Geneva, Aug. 31 -- International Clinical Trials Registry received information related to the study (ACTRN12626001018303) titled 'Physiological Biomarker-Based Neural Dosing Study: ... Read More
Geneva, Aug. 31 -- International Clinical Trials Registry received information related to the study (ACTRN12626001019392) titled 'Does Catheter Ablation Improve Cognitive Function Over 12 and 24 Month... Read More
Geneva, Aug. 31 -- International Clinical Trials Registry received information related to the study (ACTRN12626001016325) titled 'Gait Training in Dementia' on Aug. 18. Study Type: Interventional S... Read More
Geneva, Aug. 31 -- International Clinical Trials Registry received information related to the study (ACTRN12626001015336) titled 'Biomechanical effects of 3D-printed metamaterial foot orthoses with an... Read More
Tokyo, Aug. 21 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062598) titled 'Multicenter Prospective Observational Study of Immune Checkpoint Inhibitor ... Read More
Singapore, Aug. 17 -- The Health Sciences Authority received information related to the study titled 'An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination with Pembr... Read More
Singapore, Aug. 17 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-label, Phase 3 Study of Rina-S ± Bevacizumab Versus Investigator's Choice of Pl... Read More
Singapore, Aug. 17 -- The Health Sciences Authority received information related to the study titled 'ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Com... Read More
Singapore, Aug. 17 -- The Health Sciences Authority received information related to the study titled 'A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared w... Read More
Singapore, Aug. 17 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Investigator Choice of Chemothera... Read More